Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_provenance.
- NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_assertion description "[Our results show that especially for primary tumors containing stromal elements, the assessment of mRNA expression levels of ADAM-9 and ADAM-11 could be useful to identify patients with recurrent breast cancer who are likely to benefit or fail from tamoxifen therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_provenance.
- NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_assertion evidence source_evidence_literature NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_provenance.
- NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_assertion SIO_000772 16243802 NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_provenance.
- NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_assertion wasDerivedFrom befree-20140225 NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_provenance.
- NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_assertion wasGeneratedBy ECO_0000203 NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP750262.RAyd7jBFibYXv9-Npb7jm-rUyZUffXhR1i9Wv47gCTPYk130_provenance.